Status:
COMPLETED
Precision Sleep Medicine
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Rekonas GmbH
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
Brief Summary
This retrospective observational study aims to characterize the prevalence and clinical features of obstructive sleep apnea (OSA) phenotypes and develop a rater-independent algorithm for automated OSA...
Detailed Description
Obstructive sleep apnea (OSA) is characterized by repeated upper airway blockages during sleep, but it presents with a range of phenotypic variations, each with potentially distinct clinical implicati...
Eligibility Criteria
Inclusion
- age 19 years and older (data from University Hospital Basel (USB))
- age 18 years or younger (data from University Children's Hospital Basel (UKBB))
- Epworth Sleepiness Scale (ESS) score available (USB only)
- Diagnosis available (e.g. Obstructive sleep apnea (OSA), Central Sleep Apnea (CSA), Cheyne Stokes Breathing (CSR), ...)
- signed written general consent
Exclusion
- history of treatment of sleep apnea
- tracheostomy
- current home oxygen therapy
- decline to sign the written general consent, or absence of written general consent
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
1055 Patients enrolled
Trial Details
Trial ID
NCT06903481
Start Date
January 1 2022
End Date
July 31 2024
Last Update
March 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031
2
University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031